Selected research
Market Outlook & Growth Opportunities
Global ELISA Service Market Outlook and Growth Opportunities 2026
Market perspective
The global ELISA Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for ELISA Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for ELISA Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for ELISA Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the ELISA Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the ELISA Service market include Virology Research Services Ltd, ACROBiosystems, Boster Bio, RayBiotech, Inc, Precision Medicine Group, LLC, Bio-Techne, Cellular Technology Limited(immunospot), Sino Biological, Inc and R&D Systems, Inc, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global ELISA Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of ELISA Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents ELISA Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global ELISA Service market.
ELISA Service Segment by Company
Virology Research Services Ltd
ACROBiosystems
Boster Bio
RayBiotech, Inc
Precision Medicine Group, LLC
Bio-Techne
Cellular Technology Limited(immunospot)
Sino Biological, Inc
R&D Systems, Inc
ProteoGenix
Eve Technologies
NorthEast BioAnalytical Laboratories LLC
mabtech
Pestka Biomedical Laboratories, Inc
Thermo Fisher Scientific
Antibodies Incorporated
Kaneka Eurogentec S.A
ELISA Service Segment by Type
Direct ELISA
Indirect ELISA
Sandwich ELISA
Competitive ELISA
ELISA Service Segment by Application
Disease Diagnosis
Vaccine Effectiveness Evaluation
Drug Development
Allergen Testing
Others
ELISA Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global ELISA Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the ELISA Service key companies, revenue, market share, and recent developments.
3. To split the ELISA Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions ELISA Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify ELISA Service significant trends, drivers, influence factors in global and regions.
6. To analyze ELISA Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ELISA Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of ELISA Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ELISA Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global ELISA Service industry.
Chapter 3: Detailed analysis of ELISA Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of ELISA Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of ELISA Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Direct ELISA
- Indirect ELISA
- Sandwich ELISA
- Competitive ELISA
Applications
- Disease Diagnosis
- Vaccine Effectiveness Evaluation
- Drug Development
- Allergen Testing
- Others
Companies covered
- Virology Research Services Ltd
- ACROBiosystems
- Boster Bio
- RayBiotech, Inc
- Precision Medicine Group, LLC
- Bio-Techne
- Cellular Technology Limited(immunospot)
- Sino Biological, Inc
- R&D Systems, Inc
- ProteoGenix
- Eve Technologies
- NorthEast BioAnalytical Laboratories LLC
- mabtech
- Pestka Biomedical Laboratories, Inc
- Thermo Fisher Scientific
- Antibodies Incorporated
- Kaneka Eurogentec S.A
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global ELISA Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global ELISA Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 ELISA Service Market Dynamics
- 2.1 ELISA Service Industry Trends
- 2.2 ELISA Service Industry Drivers
- 2.3 ELISA Service Industry Opportunities and Challenges
- 2.4 ELISA Service Industry Restraints
3 ELISA Service Market by Company
- 3.1 Global ELISA Service Company Revenue Ranking in 2025
- 3.2 Global ELISA Service Revenue by Company (2021-2026)
- 3.3 Global ELISA Service Company Ranking (2024-2026)
- 3.4 Global ELISA Service Company Manufacturing Base and Headquarters
- 3.5 Global ELISA Service Company Product Type and Application
- 3.6 Global ELISA Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global ELISA Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 ELISA Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 ELISA Service Market by Type
- 4.1 ELISA Service Type Introduction
- 4.1.1 Direct ELISA
- 4.1.2 Indirect ELISA
- 4.1.3 Sandwich ELISA
- 4.1.4 Competitive ELISA
- 4.2 Global ELISA Service Sales Value by Type
- 4.2.1 Global ELISA Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global ELISA Service Sales Value by Type (2021-2032)
- 4.2.3 Global ELISA Service Sales Value Share by Type (2021-2032)
5 ELISA Service Market by Application
- 5.1 ELISA Service Application Introduction
- 5.1.1 Disease Diagnosis
- 5.1.2 Vaccine Effectiveness Evaluation
- 5.1.3 Drug Development
- 5.1.4 Allergen Testing
- 5.1.5 Others
- 5.2 Global ELISA Service Sales Value by Application
- 5.2.1 Global ELISA Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global ELISA Service Sales Value by Application (2021-2032)
- 5.2.3 Global ELISA Service Sales Value Share by Application (2021-2032)
6 ELISA Service Regional Value Analysis
- 6.1 Global ELISA Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global ELISA Service Sales Value by Region (2021-2032)
- 6.2.1 Global ELISA Service Sales Value by Region: 2021-2026
- 6.2.2 Global ELISA Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America ELISA Service Sales Value (2021-2032)
- 6.3.2 North America ELISA Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe ELISA Service Sales Value (2021-2032)
- 6.4.2 Europe ELISA Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific ELISA Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific ELISA Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America ELISA Service Sales Value (2021-2032)
- 6.6.2 South America ELISA Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa ELISA Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa ELISA Service Sales Value Share by Country, 2025 VS 2032
7 ELISA Service Country-level Value Analysis
- 7.1 Global ELISA Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global ELISA Service Sales Value by Country (2021-2032)
- 7.2.1 Global ELISA Service Sales Value by Country (2021-2026)
- 7.2.2 Global ELISA Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA ELISA Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada ELISA Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico ELISA Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany ELISA Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France ELISA Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. ELISA Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy ELISA Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain ELISA Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia ELISA Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands ELISA Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries ELISA Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China ELISA Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan ELISA Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea ELISA Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India ELISA Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia ELISA Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia ELISA Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil ELISA Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina ELISA Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile ELISA Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia ELISA Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru ELISA Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia ELISA Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel ELISA Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE ELISA Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey ELISA Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran ELISA Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran ELISA Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt ELISA Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt ELISA Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt ELISA Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Virology Research Services Ltd
- 8.1.1 Virology Research Services Ltd Company Information
- 8.1.2 Virology Research Services Ltd Business Overview
- 8.1.3 Virology Research Services Ltd ELISA Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Virology Research Services Ltd ELISA Service Product Portfolio
- 8.1.5 Virology Research Services Ltd Recent Developments
- 8.2 ACROBiosystems
- 8.2.1 ACROBiosystems Company Information
- 8.2.2 ACROBiosystems Business Overview
- 8.2.3 ACROBiosystems ELISA Service Revenue and Gross Margin (2021-2026)
- 8.2.4 ACROBiosystems ELISA Service Product Portfolio
- 8.2.5 ACROBiosystems Recent Developments
- 8.3 Boster Bio
- 8.3.1 Boster Bio Company Information
- 8.3.2 Boster Bio Business Overview
- 8.3.3 Boster Bio ELISA Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Boster Bio ELISA Service Product Portfolio
- 8.3.5 Boster Bio Recent Developments
- 8.4 RayBiotech, Inc
- 8.4.1 RayBiotech, Inc Company Information
- 8.4.2 RayBiotech, Inc Business Overview
- 8.4.3 RayBiotech, Inc ELISA Service Revenue and Gross Margin (2021-2026)
- 8.4.4 RayBiotech, Inc ELISA Service Product Portfolio
- 8.4.5 RayBiotech, Inc Recent Developments
- 8.5 Precision Medicine Group, LLC
- 8.5.1 Precision Medicine Group, LLC Company Information
- 8.5.2 Precision Medicine Group, LLC Business Overview
- 8.5.3 Precision Medicine Group, LLC ELISA Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Precision Medicine Group, LLC ELISA Service Product Portfolio
- 8.5.5 Precision Medicine Group, LLC Recent Developments
- 8.6 Bio-Techne
- 8.6.1 Bio-Techne Company Information
- 8.6.2 Bio-Techne Business Overview
- 8.6.3 Bio-Techne ELISA Service Revenue and Gross Margin (2021-2026)
- 8.6.4 Bio-Techne ELISA Service Product Portfolio
- 8.6.5 Bio-Techne Recent Developments
- 8.7 Cellular Technology Limited(immunospot)
- 8.7.1 Cellular Technology Limited(immunospot) Company Information
- 8.7.2 Cellular Technology Limited(immunospot) Business Overview
- 8.7.3 Cellular Technology Limited(immunospot) ELISA Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Cellular Technology Limited(immunospot) ELISA Service Product Portfolio
- 8.7.5 Cellular Technology Limited(immunospot) Recent Developments
- 8.8 Sino Biological, Inc
- 8.8.1 Sino Biological, Inc Company Information
- 8.8.2 Sino Biological, Inc Business Overview
- 8.8.3 Sino Biological, Inc ELISA Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Sino Biological, Inc ELISA Service Product Portfolio
- 8.8.5 Sino Biological, Inc Recent Developments
- 8.9 R&D Systems, Inc
- 8.9.1 R&D Systems, Inc Company Information
- 8.9.2 R&D Systems, Inc Business Overview
- 8.9.3 R&D Systems, Inc ELISA Service Revenue and Gross Margin (2021-2026)
- 8.9.4 R&D Systems, Inc ELISA Service Product Portfolio
- 8.9.5 R&D Systems, Inc Recent Developments
- 8.10 ProteoGenix
- 8.10.1 ProteoGenix Company Information
- 8.10.2 ProteoGenix Business Overview
- 8.10.3 ProteoGenix ELISA Service Revenue and Gross Margin (2021-2026)
- 8.10.4 ProteoGenix ELISA Service Product Portfolio
- 8.10.5 ProteoGenix Recent Developments
- 8.11 Eve Technologies
- 8.11.1 Eve Technologies Company Information
- 8.11.2 Eve Technologies Business Overview
- 8.11.3 Eve Technologies ELISA Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Eve Technologies ELISA Service Product Portfolio
- 8.11.5 Eve Technologies Recent Developments
- 8.12 NorthEast BioAnalytical Laboratories LLC
- 8.12.1 NorthEast BioAnalytical Laboratories LLC Company Information
- 8.12.2 NorthEast BioAnalytical Laboratories LLC Business Overview
- 8.12.3 NorthEast BioAnalytical Laboratories LLC ELISA Service Revenue and Gross Margin (2021-2026)
- 8.12.4 NorthEast BioAnalytical Laboratories LLC ELISA Service Product Portfolio
- 8.12.5 NorthEast BioAnalytical Laboratories LLC Recent Developments
- 8.13 mabtech
- 8.13.1 mabtech Company Information
- 8.13.2 mabtech Business Overview
- 8.13.3 mabtech ELISA Service Revenue and Gross Margin (2021-2026)
- 8.13.4 mabtech ELISA Service Product Portfolio
- 8.13.5 mabtech Recent Developments
- 8.14 Pestka Biomedical Laboratories, Inc
- 8.14.1 Pestka Biomedical Laboratories, Inc Company Information
- 8.14.2 Pestka Biomedical Laboratories, Inc Business Overview
- 8.14.3 Pestka Biomedical Laboratories, Inc ELISA Service Revenue and Gross Margin (2021-2026)
- 8.14.4 Pestka Biomedical Laboratories, Inc ELISA Service Product Portfolio
- 8.14.5 Pestka Biomedical Laboratories, Inc Recent Developments
- 8.15 Thermo Fisher Scientific
- 8.15.1 Thermo Fisher Scientific Company Information
- 8.15.2 Thermo Fisher Scientific Business Overview
- 8.15.3 Thermo Fisher Scientific ELISA Service Revenue and Gross Margin (2021-2026)
- 8.15.4 Thermo Fisher Scientific ELISA Service Product Portfolio
- 8.15.5 Thermo Fisher Scientific Recent Developments
- 8.16 Antibodies Incorporated
- 8.16.1 Antibodies Incorporated Company Information
- 8.16.2 Antibodies Incorporated Business Overview
- 8.16.3 Antibodies Incorporated ELISA Service Revenue and Gross Margin (2021-2026)
- 8.16.4 Antibodies Incorporated ELISA Service Product Portfolio
- 8.16.5 Antibodies Incorporated Recent Developments
- 8.17 Kaneka Eurogentec S.A
- 8.17.1 Kaneka Eurogentec S.A Company Information
- 8.17.2 Kaneka Eurogentec S.A Business Overview
- 8.17.3 Kaneka Eurogentec S.A ELISA Service Revenue and Gross Margin (2021-2026)
- 8.17.4 Kaneka Eurogentec S.A ELISA Service Product Portfolio
- 8.17.5 Kaneka Eurogentec S.A Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst